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Collier JJ, Batdorf HM, Mendoza TM, Burk DH, Martin TM,
Zhang J, Mynatt RL, Burke SJ. Hepatic IKKε expression is dis-
pensable for high-fat feeding-induced increases in liver lipid content
and alterations in glucose tolerance. Am J Physiol Endocrinol Metab
318: E11–E21, 2020. First published October 29, 2019; doi:10.1152/
ajpendo.00309.2019.—There are endocrine and immunological
changes that occur during onset and progression of the overweight and
obese states. The inhibitor of nuclear factor-B kinase-ε (IKKε) was
originally described as an inducible protein kinase; whole body gene
deletion or systemic pharmaceutical targeting of this kinase improved
insulin sensitivity and glucose tolerance in mice. To investigate the
primary sites of action associated with IKKε during weight gain, we
describe the first mouse line with conditional elimination of IKKε in
the liver (IKKεAlb–/–). IKKεAlb–/– mice and littermate controls gain
weight, show similar changes in body composition, and do not display
any improvements in insulin sensitivity or whole body glucose toler-
ance. These studies were conducted using breeder chow diets and
matched low- vs. high-fat diets. While glycogen accumulation in the
liver is reduced in IKKεAlb–/– mice, lipid storage in liver is similar in
IKKεAlb–/– mice and littermate controls. Our results using IKKεAlb–/–
mice suggest that the primary action of this kinase to impact insulin
sensitivity during weight gain lies predominantly within extrahepatic
tissues.
glucose homeostasis; glucose metabolism; inflammation; liver; me-
tabolism; obesity
INTRODUCTION
The overweight and obese conditions are associated with
increased risk for adverse metabolic events (e.g., insulin resis-
tance) and onset of other pathological states, including cardio-
vascular disease, dementia, stroke, and type 2 diabetes (2,
12–15, 27). As body mass increases, especially augmented
adiposity, a number of endocrine and immunological changes
are also present, such as hyperinsulinemia, increased cytokine
production, and a subclinical, persistent, low-grade inflamma-
tion (16, 17, 23, 24). A variety of specific inflammatory
signaling pathways have been suggested to interfere with
insulin action, including those induced by tumor necrosis
factor- (TNF) as well as fatty acids via signaling through
Toll-like receptors 2 and 4 (1, 19, 20, 34).
However, the contribution of inflammation to obesity-in-
duced onset of insulin resistance and alterations in glucose
homeostasis are still incompletely understood. For example,
early work indicated that IB kinase- (IKK) was linked with
insulin resistance observed during high-fat feeding (1). Reduc-
ing function of this kinase by genetic approaches or by using
salicylates improved insulin sensitivity in mice fed high-fat
diets (1, 25). Alternatively, a separate study showed that
enhancing the activity of IKK in adipose tissue of mice led to
reduced weight gain during and after high-fat feeding due to
increased energy expenditure; these phenotypes occurred de-
spite increased food intake (21). In addition, signaling through
IKK is required for proper adipose tissue expansion and the
increase in anti-inflammatory cytokines (26, 33). Thus, inflam-
matory signaling pathways, which include the various associ-
ated kinases, IKK, IKKε, etc., confer both physiological and
pathophysiological outcomes.
Although classical inflammatory signals clearly influence
insulin signaling and whole body glucose disposal, the primary
tissue depot and intermediaries responsible have not yet been
fully established. The protein kinase IKKε has been reported to
be increased by high-fat feeding in adipose tissue and liver in
mice, where it was linked with reductions in insulin signaling
(10). The link between IKKε and obesity-associated patholo-
gies, such as insulin resistance and impaired glucose tolerance,
is based on whole body genetic as well as systemic pharma-
cological approaches (10, 30). Although informative, these
strategies do not allow for delineation between primary and
secondary responses or identification of the tissue(s) most
likely to be dependent on IKKε activity. Consequently, the
identification of distinct tissue depots responsible for the major
outcomes associated with IKKε activity during diet-induced
obesity have not yet been described.
To address these possibilities, we generated a mouse with
conditional IKKε alleles by placement of loxP sites around
exons 3 and 4 of the coding region. To our knowledge, this is
the first description of a tissue-specific targeting of the gene
encoding the IKKε protein. This novel mouse model provides
the ability to spatially and temporally eliminate IKKε expres-
sion and signaling using tissue-specific constitutive or induc-
ible Cre recombinase expression. Herein, we report that liver-
specific deletion of IKKε does not alter body weight or provide
protection against impaired glucose tolerance induced by high-
fat feeding. Although there are modest changes in liver lipid
and glycogen storage, IKKε appears dispensable for develop-
ment of insulin resistance and impaired glucose tolerance in
response to consumption of a high-fat diet. Thus, we conclude
that hepatic IKKε is unlikely to contribute significantly to
adverse metabolic sequelae during obesity.
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MATERIALS AND METHODS
Construction of mice with conditional IKK alleles. The targeting
vector consisting of a 5-kb 5= arm and 4.2-kb 3= arm was constructed
using a recombination-mediated genetic engineering system. Isogenic
DNA containing the Ibk gene was retrieved from genomic colony
RP23-239k17 of C57BL/6 BAC genomic library via gap repair. The
first loxp sequence was inserted within intron 2 and the Frt-neo-Frt-
Loxp into intron 4 to generate the targeting vector so as to flank exons
3 and 4. For gene targeting, 50 g of linearized targeting vector was
electroporated into B6 embryonic stem (ES) cells. Correct homolo-
gous recombination in targeted clones was confirmed with Fidelity
PCR at the 5= end and the 3= end. The fragments produced from
Fidelity PCR with these primers were sequenced to further verify the
correctness of recombination. Three different colonies of targeted ES
cells were injected into Albino B6 blastocysts, and germline trans-
mitting chimeric mice were identified. These mice were then mated
with Albino B6 mice to generate heterozygous offspring on a pure
C57BL/6J background.
Generation and use of mice with hepatocyte-specific deletion of
IKK. Mice with a liver-specific deletion of IKKε were generated by
crossing IKbke floxed mice with Alb-Cre mice (stock no. 003574; The
Jackson Laboratory, Bar Harbor, ME). Mice were housed with a
12:12-h light-dark cycle in a temperature- (22  2°C) and humidity-
controlled (45–55%) room with ad libitum access to food and water.
Blood glucose measurements were taken using the Bayer Breeze 2
Glucometer (Bayer HealthCare LLC, Mishawaka, IN). Body compo-
sition was assessed by nuclear magnetic resonance (NMR) using a
Bruker Minispec LF110 Time-Domain NMR system. Littermates
were used as controls, with three to four separate cohorts of mice bred
to complete all studies. For individual studies, animals were given
access to either Laboratory Diet 5015 (Purina, St. Louis, MO) or
low-fat (D12450H; 10% kcal fat, Research Diets, Inc., New Bruns-
wick, NJ) vs. high-fat (D12451; 45% kcal fat; sucrose-matched) diets.
Upon completion of the study periods, animals were fasted for 2–4 h
and euthanized by CO2 asphyxiation followed by decapitation. Trunk
blood was collected, and the serum fraction was separated. Tissues
were snap-frozen in liquid nitrogen and stored at 80°C.
Glucose and insulin tolerance tests. Glucose (GTT) and insulin
tolerance tests (ITT) were performed as previously described (3, 6).
Glucose tolerance was determined by administration of a 20% glucose
solution at a concentration of 2.5 g/kg body wt via intraperitoneal
injection following a 4-h fast. Blood samples were taken from the tail
vein at 0, 20, 40, 60, and 120 min after injection. To determine insulin
tolerance, animals were given an intraperitoneal injection of Humulin
R insulin (Lilly, Indianapolis, IN) at a concentration of 1.0 U/kg
lean mass following a 2-h fast. Blood glucose was read before
injection and again at 15, 30, 45, 60, 90, and 120 min postinjection
using a Bayer Contour Blood Glucose Meter. All studies were
approved by the Pennington Biomedical Research Center Institutional
Animal Care and Use Committee.
Total RNA extraction, cDNA synthesis, and real-time RT-PCR. Total
RNA was extracted from 30 mg of liver tissue using the Quick-RNA
Miniprep Kit from Zymo Research (Irvine, CA). Procedures for cDNA
synthesis, primer design, and RT-PCR were as described (4, 7, 9).
Glycogen and total acyl glycerol measurements. Glycogen and
total acyl glycerol were measured using extracts from powdered liver
tissue. Reagents and procedures for both assays have been reported in
detail (5, 6). Briefly, glycogen was determined from 10 mg of
Fig. 1. Generation of mice with liver-specific inhibitor of NF-B kinase-ε (IKKε) deletion (IKKεAlb/). A: schema showing generation of a targeting construct
to produce mice with conditional IKKε alleles. B: protein abundance of IKKε in liver tissue from male IKKεfl/fl (control, /) and IKKεAlb/ (/) mice.
Molecular weight markers shown. Immunoblot was performed on 3 separate occasions; representative image is shown. Liver-specific deletion was confirmed by
measuring Cre expression in liver (n 	 26 per group; C), and Ikbke gene expression in liver (n 	 8 per group; D) and epididymal white adipose tissue (eWAT)
(n 	 6 per group) from male mice. ****P 
 0.0001, *P 
 0.05.
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powdered tissue with the Glycogen Assay Kit from Abcam (cat. no.
ab65620) according to the manufacturer’s protocol. Total acyl glyc-
erol was determined from 30 mg of powdered tissue using the
Triglyceride Determination Kit from Sigma (cat. no. TR0100-1KT).
Immunohistochemistry, immunoprecipitation, and Western blotting.
Our methods for formalin fixation, paraffin embedding, and sectioning
have been described previously (5, 8). Briefly, tissue was fixed in 10%
neutral buffered formalin for 24–48 h and embedded in paraffin, and
5 m sections were collected on positively charged slides. IBA-1
antibody was from Abcam (ab5076).
For detection of IKKε by immunoprecipitation/Western blotting,
mouse liver tissue (30–40 mg) was washed with 1 mL of ice-cold
PBS with protease inhibitors (Thermo Fisher) and centrifuged at 500
g for 2 min at 4°C. Supernatant was removed, and the tissue was
resuspended in 600 L of T-PER (Thermo Fisher) with protease
inhibitors and homogenized using a cordless pellet pestle (Kimble
Chase). The homogenized tissue was incubated on ice for 15 min for
lysis and then centrifuged at 12,000 g for 10 min at 4°C. Lysates were
sonicated on a Bioruptor Pico (Diagenode) for 10 cycles (30 s on, 30
s off). Protein content was quantified by BCA assay (Thermo Fisher);
750 g of the sonicated protein was precleared with 10 L of protein
G dynabeads (Thermo Fisher) with rotation for 1 h at 4°C. The beads
were removed, and samples were diluted 10-fold in immunoprecipi-
tation buffer (1% Triton X-100, 2 mM EDTA, 150 mM NaCl, 20 mM
Tris) with protease inhibitors followed by the addition of 1 g of
IKKε antibody (Ubiquigent, Scotland, UK; 68-0051-100) or control
mouse IgG. Samples were rotated overnight at 4°C followed by
addition of 10 L of protein G dynabeads. The samples were rotated
for 30 min at 4°C and then 15 min at room temperature. Bead-
antibody-protein complexes were pulled down by magnet and washed
three times with cold dilution buffer for 5 min at 4°C with rotation.
Samples were resuspended in 40 L of NuPAGE LDS sample buffer
(Thermo Fisher) with 4 L of NuPAGE sample reducing agent
(Thermo Fisher) and incubated at 70°C for 10 min. Denatured proteins
were separated on 4–12% Bis-Tris gel (Thermo Fisher) and trans-
ferred to a polyvinylidene difluoride membrane. The membrane was
blocked with membrane blocking solution (Invitrogen) for 15 min,
washed with TBS, and then incubated with IKKε primary antibody
(mouse monoclonal, Bio-Rad, cat. no. VMA00517) overnight with
rocking at 4°C. After removal of the primary antibody, the membrane
was washed twice for 5 min each time at room temperature with
TBS  0.05% Tween and then once with TBS. The secondary
antibody (horseradish peroxidase-linked anti-mouse IgG; Cell Signal-
ing no. 7076) was added at 1:10,000 dilution in TBS with 1%
polyvinylpyrrolidone and 0.025% Tween and allowed to incubate for
2 h at room temperature. After removal of the secondary antibody, the
membrane was again washed twice with TBS  Tween followed by
one wash with TBS. The membrane was incubated with Clarity
Western ECL Substrate (Bio-Rad, no. 1705060S) and imaged on a
ChemiDoc XRS System.
Statistical analysis. Statistical analysis was performed using GraphPad
Prism 6.07 (GraphPad Software, La Jolla, CA). Data were analyzed
by either one-way ANOVA using Tukey’s post hoc, repeated-mea-
sures ANOVA (for longitudinal measures of body weight and body
composition) or two-tailed Student’s t test. Data are represented as
means  SE.
RESULTS
Hepatocyte-targeted deletion of IKK does not alter body
weight or lean mass. Global deletion of IKKε was reported to
improve glucose tolerance, with enhanced insulin sensitivity in
liver (10). Because the liver is critical for glucose homeostasis
(11), we generated mice with conditional alleles (schema
shown in Fig. 1A) and crossed them to mice expressing Cre
recombinase under the control of the albumin promoter to
investigate the role of IKKε in hepatocytes. A reduction in
Fig. 2. Hepatocyte-targeted deletion of in-
hibitor of NF-B kinase (IKKε) does not
alter body weight or lean mass. IKKε/,
IKKεfl/fl control; IKKεAlb/, with condi-
tional elimination of IKKε in liver. Body
mass (A), fat mass (B), lean mass (C), and
fluid mass (D) of male mice. Red squares
indicate floxed littermate controls; blue cir-
cles represent IKKεAlb/ mice (n 	 10 per
group). #P 
 0.1.
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IKKε protein (Fig. 1B) in Cre-positive mice was consistent
with Cre expression in liver tissue (Fig. 1C). In addition, IKKε
mRNA was reduced in liver (Fig. 1D) in a genotype-dependent
manner, whereas high-fat feeding suppressed expression of the
Ibkε gene in epididymal white adipose tissue (Fig. 1E).
We found that both IKKεfl/fl and IKKεAlb/ mice had
similar body weights when fed nonpurified (breeder chow)
diets (Fig. 2A). We observed that at ~20 wk of age IKKεAlb/
mice displayed modest reductions in whole body fat mass that
rebounded to the level of IKKεfl/fl littermate controls by week
25 (Fig. 2B). Lean mass (Fig. 2C) and fluid mass (Fig. 2D)
were similar between the groups.
Hepatic IKK does not protect against changes in glucose
tolerance. At 12 wk of age, glucose tolerance was similar
between IKKεfl/fl and IKKεAlb/ mice (Fig. 3A). Insulin
sensitivity, measured by ITT, was also comparable between the
groups (Fig. 3B). Glucose tolerance at 20 wk of age remained
similar between IKKεfl/fl and IKKεAlb/ mice (Fig. 3C).
Thus, we next investigated whether a lower dose of glucose,
one-half the amount given in Fig. 3, A and C, would reveal
changes in sensitivity to this stimulus. We found that even with
a lower concentration of glucose the IKKεfl/fl and IKKεAlb/
mice remained nearly identical in their responses to a glucose
challenge (Fig. 3D).
Liver glycogen and lipid content were similar between IKKfl/fl
and IKKAlb/ mice. With no changes in glucose tolerance or
insulin sensitivity, we investigated whether IKKε might regu-
late the ability to store metabolic substrates in the form of
glycogen or lipid. Although glycogen content trended higher in
the IKKεAlb/ mice, this parameter did not reach statistical
significance (Fig. 4A). Similarly, liver lipid content trended
lower in IKKεAlb/ mice relative to IKKεfl/fl mice, but was
not significant (Fig. 4B). In addition, expression of the G6pc
gene was not different in either group (Fig. 4C). Comparable
with Fig. 4A, the gene encoding glycogen synthase (Gys1)
trended higher in IKKεAlb/ mice (Fig. 4D). There were no
noticeable alterations in the expression of the Acaca (acetyl-
CoA carboxylase) or Fasn (fatty acid synthase) genes (Figs. 4,
E and F).
High-fat feeding produces increases in body weight and fat
mass that are independent of hepatic IKK. We next tested the
hypothesis that IKKε in liver mediates high-fat feeding-in-
duced alterations in body weight and glucose tolerance. For
these experiments, a separate cohort of mice was bred and then
placed on matched low- (10% kcal) or high-fat (45% kcal)
diets. We found that high-fat feeding increased body weights
but that IKKε did not influence weight gain (Fig. 5A). Simi-
larly, fat mass (Fig. 5B), lean mass (Fig. 5C), and fluid mass
(Fig. 5D) were comparable between the IKKεfl/fl and IKKεAlb/
mice.
Glucose and insulin tolerance are similar between IKKfl/fl
and IKKAlb/ mice fed a high-fat diet. Even though it has
been reported that high-fat feeding induces the expression of
IKKε in the liver (10), we found that glucose tolerance in the
IKKεfl/fl and IKKεAlb/ mice were similar when fed either
low-fat (Fig. 6A) or high-fat diets for 8 wk [Fig. 6B; area under
the curve (AUC) for both diets and genotypes given in Fig.
6C]. In addition, after 12 wk on each diet, IKKεfl/fl and
IKKεAlb/ mice were comparable in their sensitivity to a
bolus intraperitoneal (ip) insulin injection (Fig. 6, D and E;
Fig. 3. Hepatocyte inhibitor of NF-B ki-
nase-ε (IKKε) is dispensable for glucose toler-
ance. IKKε/, IKKεfl/fl control; IKKεAlb/,
with conditional elimination of IKKε in liver.
Glucose tolerance tests (GTT) conducted in
12-wk- (A), 20-wk- (C), and 24-wk-old (D)
male mice. C: Insulin tolerance test (ITT) at 16
wk of age. Red squares indicate floxed litter-
mate controls; blue circles represent IKKεAlb/
mice (n 	 10 per group).
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AUC shown in Fig. 6F). Despite very clear differences in
dietary effect on body weight and body composition (Fig. 5),
glucose tolerance remained similar in IKKεfl/fl and IKKεAlb/
mice after 16 wk on either low- or high-fat diets (not shown).
Because there was a clear increase in fat mass in mice con-
suming a high-fat diet, we plotted the AUC as a function of fat
mass for both the GTT (Fig. 6G) and the ITT (Fig. 6H). In
addition, the terminal insulin values for mice fed low- or
high-fat diet for 18 wk is shown in Fig. 6I. Whereas high-fat
feeding increases circulating insulin, which is consistent with
insulin resistance, and also reduces both glucose and insulin
tolerance, targeted deletion of IKKε in the liver does not have
an effect on these variables compared with littermate control
mice.
Glycogen content decreases in IKKAlb/ mice fed a low-fat
diet, whereas CCL2 gene expression increases in IKKAlb/
mice fed a high-fat diet. Liver lipid content increased in mice
consuming the high-fat vs. the low-fat diet (Fig. 7A), but no
differences were apparent in IKKεAlb/ compared with
IKKεfl/fl mice (Fig. 7A). By contrast, IKKεAlb/ mice had
lower glycogen content than IKKεfl/fl mice, which manifested
only on the low-fat diet (Fig. 7B). However, the expression of
the Gys1 gene, encoding glycogen synthase, was not different
between the IKKεAlb/ or IKKεfl/fl mice (Fig. 7C), whereas
Gys2 expression was increased by high-fat diet (Fig. 7C). The
Acaca gene trended lower in IKKεAlb/ relative to IKKεfl/fl
mice on the low-fat diet (P 	 0.07; Fig. 7D), although there
was no genotype-dependent change during high-fat feeding. In
addition, expression of Fasn, encoding fatty acid synthase (Fig.
7E), or Cpt1a, encoding carnitine palmitoyltransferase-1a (Fig.
7F), were unchanged between IKKεAlb/ and IKKεfl/fl mice.
The expression of G6pc, encoding glucose-6-phosphatase cat-
alytic subunit (Fig. 7G), and Chuk (aka IKK), encoding the
inhibitor of NF-B kinase complex (Fig. 7H), were also un-
changed. By contrast, the expression of Tbk1 was increased by
high-fat diet (Fig. 7I). Tbk1 encodes the TANK-binding ki-
Fig. 4. Liver glycogen and lipid content
were similar between IKKεfl/fl (Alb/)
and IKKεAlb/ mice. IKKε, inhibitor of
NF-B kinase-ε; IKKε/, IKKεfl/fl con-
trol; IKKεAlb/, with conditional elimi-
nation of IKKε in liver. Glycogen (A) and
total acyl glycerol (B) measurements. Ex-
pression of the G6pc (glucose-6-phospha-
tase; C), Gys1 (glycogen synthase; D),
Acaca (acetyl-CoA carboxylase; E), and
Fasn (fatty acid synthase; F) genes in liver
tissue from 30-wk-old male IKKεfl/fl and
IKKεAlb/ mice (n 	 10 per group).
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nase-1, which can activate the NF-B pathway (29). In addi-
tion, expression of several genes linked with NF-B activation
was decreased in epididymal white adipose tissue (eWAT; Fig.
7, J–L).
Further analyses of gene expression in eWAT revealed
increases in the expression of various chemokines in re-
sponse to high-fat feeding (Fig. 8, A–C). Of these three
genes, the Cxcl10 gene was reduced in eWAT when liver
IKKε was absent (Fig. 8C). We noted an IKKε-dependent
increase in the expression of the Ccl2 gene in the liver of
IKKεAlb/ mice fed a high-fat diet (Fig. 8D); Ccl2 encodes
a chemokine that recruits monocytes and macrophages.
There was no change in expression of Ccl3 (Fig. 8E),
whereas Ccl5 trended lower in IKKεAlb/ mice fed a
high-fat diet (Fig. 8F). The genes encoding chemokines
CXCL10 (Fig. 8G), CCL20 (Fig. 8H), and the Kupffer cell
marker Clec4f (Fig. 8I) were all unchanged in the liver in
response to either diet or in response to hepatic IKKε
deletion. Total liver macrophages were also unchanged in
IKKεfl/fl and IKKεAlb/ mice (Fig. 8J). Taken together,
although hepatocyte IKKε abundance may regulate glyco-
gen accumulation during the consumption of a low-fat diet
and selected genes in response to high-fat diet, there was no
impact on whole body glucose tolerance or insulin sensitiv-
ity.
DISCUSSION
IKKε has been linked with whole body insulin resistance in
response to high-fat feeding; whole body genetic deletion or
systemic pharmacological inhibition of this kinase improves
insulin sensitivity and glucose homeostasis (10, 30). While
informative, global gene deletion and systemic approaches do
not allow identification of the primary vs. secondary sites of
IKKε action. To address this possibility, we have, to our
knowledge, generated the first mouse with IKKε floxed alleles
to study tissue-specific outcomes associated with deletion of
this kinase.
Our novel data reveal that hepatic IKKε is unlikely to be a
critical factor controlling whole body glucose homeostasis
during high-fat feeding. We found that deletion of IKKε in the
liver does not influence lipid storage (Fig. 7A) and only
influences glycogen storage in the low-fat-fed group (Fig. 7B).
Consistent with these findings, hepatic deletion of IKKε does
not improve whole body glucose tolerance or insulin sensitiv-
ity. On the basis of the global IKKε deletion phenotype, where
insulin sensitivity and glucose tolerance were improved (10),
we suspect that IKKε in either adipocytes or immune cells may
be the key contributor to adverse metabolic events during
diet-induced obesity. There is also evidence to suggest that
IKKε in the brain could also contribute to obesity-related
metabolic dysfunction (32).
Fig. 5. High-fat feeding in male mice produces increases in body weight and fat mass that are independent of hepatic inhibitor of NF-B kinase-ε (IKKε).
IKKε/, IKKεfl/fl control; IKKεAlb/, with conditional elimination of IKKε in liver. Body mass (A), fat mass (B), lean mass (C), and fluid mass (D) of male
mice on matched low-fat (LFD, dashed lines) or high-fat diets (HFD, solid lines) for 18 wk. Green squares indicate floxed littermate controls; gray circles
represent IKKεAlb/ mice (n 	 18–20 per group).
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Several experimental considerations are worth noting in the
current study. First, matched low- and high-fat diets were used
for comparison for diet-driven outcomes. This is important
because many reports compare nonpurified diets (often referred
to as chow diets) to purified diets. Because the term ‘chow’ is
often the default descriptor used to indicate a nonpurified diet,
it indicates a variety of separate diets (i.e., vendor, %fat, fiber
content, etc.) depending on the investigator and institution. In
addition, there are several flaws when nonpurified diets are
compared with purified diets that go beyond just macronutrient
composition, which can include differences in phytonutrients,
fiber content, micronutrient composition, etc. These possibili-
ties have been documented previously (28, 31), and each
change in the number of variables beyond fat content of the
diet may be a contributing factor to any observed phenotype(s).
Second, we have used littermate controls for all comparisons
herein describing mice with hepatic deletions of IKKε. The
importance of littermate controls is that inbred strains are not
all equivalent. For this reason, comparing littermates helps to
simplify the design to the question of interest rather than
incorporating a larger number of variables (which have been
outlined in Refs. 18 and 22). Indeed, the housing conditions of
the animals have a major influence on experimental pheno-
types. For example, mice from the same genetic strain housed
in two distinct institutions may have unrelated microbiomes,
which could compromise the findings of a given study.
Fig. 6. Glucose and insulin tolerance are similar between IKKεfl/fl and IKKεAlb/ male mice fed a matched low-fat (LFD) and high-fat (HFD) diets. IKKε,
inhibitor of NF-B kinase-ε; IKKε/, IKKεfl/fl control; IKKεAlb/, with conditional elimination of IKKε in liver. A–C: glucose tolerance tests (GTT) conducted
in male IKKεfl/fl and IKKεAlb/ mice on LFD (dashed lines; A) and HFD (solid lines; B) diets for 8 wk. C: area under the curve (AUC) for GTT shown in A
and B; open bars, IKKεfl/fl mice; filled bars, IKKεAlb/ mice. D–F: insulin tolerance test (ITT) conducted in male IKKεfl/fl and IKKεAlb/ mice on LFD (dashed
lines; D) and HFD (solid lines; E) for 12 wk. F: AUC for ITT shown in D and E; open bars, IKKεfl/fl mice; filled bars, IKKεAlb/ mice. G: Pearson correlation
of AUC from C in relation to fat mass (g) from mice on HFD for 8 wk. H: Pearson correlation of AUC from F relative to fat mass (g) from mice on HFD for
12 wk. G and H: x represents IKKefl/fl mice on LFD; squares represent IKKeAlb/ mice on LFD;  represents IKKefl/fl mice on HFD; circles represent
IKKeAlb/ mice on HFD. I: serum insulin of male mice on indicated diets for 18 wk; open bars, IKKεfl/fl mice; filled bars, IKKεAlb/ mice; n 	 18–20 per
group. ****P 
 0.0001, ***P 
 0.001, *P 
 0.05.
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Third, our study was well powered to observe even small
statistical changes between low-fat and high-fat diets. Taken
together, these considerations help to provide confidence in the
reported findings that hepatic IKKε per se is not a major
contributor to changes in whole body glucose homeostasis or
insulin sensitivity under either nonpurified diet (e.g., breeder
chow conditions) or when using low-fat and high-fat matched
diets at time points reported herein. Using these two distinct
Fig. 7. Glycogen content decreases in IKKεAlb/ mice fed a low-fat diet. IKKε, inhibitor of NF-B kinase-ε; IKKε Alb/, IKKεfl/fl control; IKKεAlb/, with
conditional elimination of IKKε in liver. Total acyl glycerol (A), glycogen (B), and gene expression measurements (C–I) of Gys1 and Gys2 (glycogen
synthase-1/2; C), Acaca (acetyl-CoA carboxylase; D), Fasn (fatty acid synthase; E), Cpt1a (carnitine palmitoyltransferase-1a; F), G6pc (glucose-6-phosphatase;
G), Chuk (IKK; H), and Tbk1 (TANK-binding kinase-1; I) genes in liver tissue, and gene expression measurements (J–L) of Chuk (J), Ikbkb (K), and Tbk1 (L)
genes in epididymal white adipose tissue (eWAT) from male IKKεfl/fl (open bars) and IKKεAlb/ (filled bars) mice on low- and high-fat diets for 18 wk. (n 	
18–20 per group for liver; n 	 6 per group for eWAT). *P 
 0.05, **P 
 0.01.
E18 HEPATIC IKKε DOES NOT INFLUENCE GLUCOSE HOMEOSTASIS
AJP-Endocrinol Metab • doi:10.1152/ajpendo.00309.2019 • www.ajpendo.org
Downloaded from journals.physiology.org/journal/ajpendo at LSU Louisiana State Univ (130.039.060.164) on August 5, 2021.
Fig. 8. Expressions of the Ccl2 and Ccl5 genes are inversely regulated by hepatic deletion of inhibitor of NF-B kinase-ε (IKKε) with no apparent changes in
liver immune cell abundance. IKKεfl/fl, control; IKKεAlb/, with conditional elimination of IKKε in liver. Ccl, C-C ligand; Cxcl, C-X-C ligand; Clec, C-type
lectin. Expression of the Ccl2 (A), Ccl3 (B), and Cxcl10 (C) genes in epididymal white adipose tissue (eWAT; n 	 6 per group), and expression of the Ccl2
(D), Ccl3 (E), Ccl5 (F), Cxcl10 (G), Ccl20 (H), and Clec4f (I) genes in liver tissue (n 	 18–20 per group), from male IKKεfl/fl (open bars) and IKKεAlb/ (filled
bars) mice on low-fat and high-fat diets for 18 wk. J: liver tissue was stained for IBA-1 (brown), which indicates the presence of macrophages. Large scale bar,
250 m; inset scale bar, 50 m. **P 
 0.01, *P 
 0.05.
E19HEPATIC IKKε DOES NOT INFLUENCE GLUCOSE HOMEOSTASIS
AJP-Endocrinol Metab • doi:10.1152/ajpendo.00309.2019 • www.ajpendo.org
Downloaded from journals.physiology.org/journal/ajpendo at LSU Louisiana State Univ (130.039.060.164) on August 5, 2021.
dietary approaches allowed us to determine whether diet-gene
interactions influenced the overall phenotype, which we did not
observe.
Finally, it is possible that redundant mechanisms exist to
control inflammation in the absence of IKKε or that hepatic
IKKε simply does not contribute a major fraction of the
signaling-induced changes in either substrate oxidation or stor-
age of nutrient molecules (e.g., glycogen, lipid, etc.). If IKKε
were constitutively overexpressed in hepatocytes, it is conceiv-
able that a different outcome might be achieved. Moreover, it
is possible that inducible deletion of IKKε might have revealed
separate outcomes, since the albumin-CRE deletes the target
gene from an early age. Future studies will likely provide
insights into any potential nuances that occur by manipulating
IKKε in adult liver. In summary, hepatic IKKε does not
contribute to impaired glucose tolerance and reductions in
insulin sensitivity in male mice fed either nonpurified (chow)
diets or commonly used matched low- and high-fat diets.
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